. To date participants in the study are completing ~60% of prompted assessments with the rate of engagement declining over the 90-day study duration. There have been no adverse reported events. Qualitative feedback from participants about the app has been positive. Conclusions: It is feasible to collect micro-cognitive measures via smartphones in patients with schizophrenia. Understanding both the validity and reliability of these new measures will require continued careful research. Background: Predicting functional outcome is a major challenge in service care of early psychosis patients (EPP). We investigated clinical and metabolic features that enable objective assessment of the risk of poor functional outcomes in early psychosis patients (EPP), using state-of-the-art topological data analysis (TDA). The guiding philosophy of TDA is that the shape of large data sets, encoded by a mathematical signature, should reveal important relations among the data points. Our primary TDA tool is Mapper, which provides unsupervised multivariate pattern analysis of high-dimensional data, producing a compressed visual representation of the data giving a strong indication of where to look for meaningful clustering. Application of Mapper has already led to a number of remarkable results, including the identification of a new subtype of breast cancer and of two phenotypically distinct types of fragile X syndrome. Methods: Recruitment: 101 EPP with informed consent were recruited from the Lausanne "Treatment and early Intervention in Psychosis Program". They had reached the psychosis threshold on the CAARMS scale. Patients were assessed at entrance of the program by PANSS and MADRS, functioning by SOFAS and GAF scales. After 3 years of clinical follow-up, EPP were evaluated for symptoms levels, social and occupational functioning. Metabolomics: Plasma extracts at the program begin were analyzed by liquid-chromatography-mass spectrometry. Features data (m/z, retention time, integrated ion intensity) were extracted using xMSanalyser v1.3.5 with apLCMS v5.9.4. Mapper: Using the Mapper algorithm, we built a topological map representing the EP cohort through the lens of the PANSS scores at baseline. The mapper algorithm captures the shape of high dimensional data through a graph. Nodes represent patients or groups of patients. Edges between nodes represent shared patients. Results: Three distinct clusters of patients could be identified: Group A, characterized by low levels of negative (N2) and depression symptoms (G6); group B, characterized by high levels of positive symptoms (P1, 6) having the worst outcome; and group C with high levels of negative (N2) and depression symptoms. Comparison of the groups after 3-years of clinical follow-up showed that group A displayed significantly better social and occupational functioning. The same grouping and predictions were confirmed in a second independent cohort of EPP. Inclusion of the metabolomics data revealed that group A had a distinct profile, which may serve as predictor of functional outcome in EEP. Conclusions: These novel findings suggest that topological analysis of a combination of symptoms and blood metabolic profile might contribute to the prediction of functional outcome at early stages of psychosis.
Background:
Predicting functional outcome is a major challenge in service care of early psychosis patients (EPP). We investigated clinical and metabolic features that enable objective assessment of the risk of poor functional outcomes in early psychosis patients (EPP), using state-of-the-art topological data analysis (TDA). The guiding philosophy of TDA is that the shape of large data sets, encoded by a mathematical signature, should reveal important relations among the data points. Our primary TDA tool is Mapper, which provides unsupervised multivariate pattern analysis of high-dimensional data, producing a compressed visual representation of the data giving a strong indication of where to look for meaningful clustering. Application of Mapper has already led to a number of remarkable results, including the identification of a new subtype of breast cancer and of two phenotypically distinct types of fragile X syndrome. Methods: Recruitment: 101 EPP with informed consent were recruited from the Lausanne "Treatment and early Intervention in Psychosis Program". They had reached the psychosis threshold on the CAARMS scale. Patients were assessed at entrance of the program by PANSS and MADRS, functioning by SOFAS and GAF scales. After 3 years of clinical follow-up, EPP were evaluated for symptoms levels, social and occupational functioning. Metabolomics: Plasma extracts at the program begin were analyzed by liquid-chromatography-mass spectrometry. Features data (m/z, retention time, integrated ion intensity) were extracted using xMSanalyser v1.3.5 with apLCMS v5.9.4. Mapper: Using the Mapper algorithm, we built a topological map representing the EP cohort through the lens of the PANSS scores at baseline. The mapper algorithm captures the shape of high dimensional data through a graph. Nodes represent patients or groups of patients. Edges between nodes represent shared patients. Results: Three distinct clusters of patients could be identified: Group A, characterized by low levels of negative (N2) and depression symptoms (G6); group B, characterized by high levels of positive symptoms (P1, 6) having the worst outcome; and group C with high levels of negative (N2) and depression symptoms. Comparison of the groups after 3-years of clinical follow-up showed that group A displayed significantly better social and occupational functioning. The same grouping and predictions were confirmed in a second independent cohort of EPP. Inclusion of the metabolomics data revealed that group A had a distinct profile, which may serve as predictor of functional outcome in EEP. Conclusions: These novel findings suggest that topological analysis of a combination of symptoms and blood metabolic profile might contribute to the prediction of functional outcome at early stages of psychosis. The talk will present recent findings from the PRONIA study (Personalized Prognostic Tools for Early Psychosis Management) demonstrating the feasibility of predicting functional and clinical outcomes in adolescents and young adults in a clinical high-risk state for psychosis (CHR) or with recent-onset depression (ROD). The talk will highlight the use of machine learning and multivariate data mining concepts and link those applications to potential clinical utility of these models for an improvement of early recognition and prevention Results: I will present and discuss the performance and decision rules generated by the machine learning analysis of clinical, imaging-based, genetic and combined data for the individualized prediction of (1) social and role functioning outcomes, (2) transition to psychosis, and (3) remission vs. non-remission from symptomatic states in CHR and ROD patients. Conclusions: The recent findings generated by the PRONIA consortium suggest that generalizable and clinical useful prediction pathways can be established to support the early recognition of adverse outcomes in CHR and ROD patients. External and prospective validation of these prognostic pathways is needed across healthcare systems to benchmark the clinical and health economic utility of these precision psychiatry methods.
IMPLEMENTING PRECISION

ULTRA HIGH-FIELD 7-TESLA NEUROIMAGING: NEW INSIGHTS INTO MECHANISMS OF PSYCHOSIS Lena Palaniyappan University of Western Ontario
The ability to visualize alive human brain's function, structure and chemical composition in ultra-high field 7-Tesla MRI has opened the doors for several neuroscientific advances in recent times. This symposium will focus on the data gathered from this high-resolution access to a patient's brain tissue to question some of the existing views on the mechanisms linked to psychosis. The symposium has the following objectives each discussed by the presenters:
(a) Dr. Frangou will demonstrate how the increased spatial resolution of 7T structural imaging enabled the development and validation of a new method for deriving lamina-specific measures of intracortical myelin. Using this measure, it is possible to identify brain regions of disrupted intracortical organization in schizophrenia that map to symptomatic severity and cognitive disruption.
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